MEDNAX Inc (MD) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC cut its holdings in shares of MEDNAX Inc (NYSE:MD) by 0.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 313,859 shares of the company’s stock after selling 2,967 shares during the quarter. Janus Henderson Group PLC owned about 0.35% of MEDNAX worth $14,646,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Point72 Hong Kong Ltd acquired a new position in MEDNAX during the second quarter worth about $172,000. NumerixS Investment Technologies Inc boosted its position in MEDNAX by 147.8% during the second quarter. NumerixS Investment Technologies Inc now owns 5,700 shares of the company’s stock worth $247,000 after acquiring an additional 3,400 shares during the last quarter. Iberiabank Corp acquired a new position in MEDNAX during the third quarter worth about $289,000. Strs Ohio acquired a new position in MEDNAX during the second quarter worth about $365,000. Finally, Financial Architects Inc acquired a new position in MEDNAX during the third quarter worth about $372,000. Hedge funds and other institutional investors own 98.16% of the company’s stock.

A number of equities analysts recently weighed in on the stock. Zacks Investment Research lowered shares of MEDNAX from a “hold” rating to a “sell” rating in a research report on Wednesday. Credit Suisse Group decreased their target price on shares of MEDNAX from $55.00 to $50.00 and set an “outperform” rating on the stock in a report on Tuesday, November 6th. Robert W. Baird decreased their target price on shares of MEDNAX from $48.00 to $40.00 and set a “neutral” rating on the stock in a report on Friday, November 2nd. Bank of America upgraded shares of MEDNAX from an “underperform” rating to a “neutral” rating and decreased their target price for the company from $60.00 to $50.00 in a report on Tuesday, September 18th. Finally, UBS Group initiated coverage on shares of MEDNAX in a report on Friday, November 16th. They issued a “sell” rating and a $37.00 target price on the stock. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $51.20.

NYSE:MD opened at $39.37 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.43 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $3.54 billion, a price-to-earnings ratio of 11.33, a PEG ratio of 1.07 and a beta of 0.32. MEDNAX Inc has a 1-year low of $37.26 and a 1-year high of $63.04.

MEDNAX (NYSE:MD) last posted its earnings results on Thursday, November 1st. The company reported $0.94 earnings per share for the quarter, missing the consensus estimate of $0.97 by ($0.03). The firm had revenue of $896.60 million during the quarter, compared to analyst estimates of $908.15 million. MEDNAX had a net margin of 9.50% and a return on equity of 10.45%. The business’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.87 earnings per share. Equities analysts expect that MEDNAX Inc will post 3.51 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at

MEDNAX Company Profile

MEDNAX, Inc, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services.

Further Reading: What is the Rule of 72?

Want to see what other hedge funds are holding MD? Visit to get the latest 13F filings and insider trades for MEDNAX Inc (NYSE:MD).

Institutional Ownership by Quarter for MEDNAX (NYSE:MD)

Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with's FREE daily email newsletter.

Leave a Reply